Garlic-derived compound -allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway

Jia XIAO; Feiyue XING; Yingxia LIU; Yi LV; Xiaogang WANG; Ming-Tat LING; Hao GAO; Songying OUYANG; Min YANG; Jiang ZHU; Yu XIA; Kwok-Fai SO; George-L TIPOE.
Acta Pharmaceutica Sinica B ; (6): 575-586, 2018.
Artículo en Inglés | WPRIM | ID: wpr-690881

Documentos relacionados

  1. Garlic-derived compound <i>S</i>-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway.
  2. IMB5036, a novel pyridazinone compound, inhibits hepatocellular carcinoma growth and metastasis.
  3. Downregulation of indolethylamine N-methyltransferase is an early event in the rat hepatocarcinogenesis and is associated with poor prognosis in hepatocellular carcinoma patients.
  4. Elevated FAM134B expression induces radiation-sensitive in hepatocellular carcinoma.
  5. CSP I-plus modified rEndostatin inhibits hepatocellular carcinoma metastasis via down-regulation of VEGFA and integrinß1.
  6. Downregulation of C12orf75 gene inhibits migration and invasion of liver cancer cell via suppressing the Wnt/ß-catenin signaling pathway in vitro.
  7. Down-regulation of Transducin-Like Enhancer of Split protein 4 in hepatocellular carcinoma promotes cell proliferation and epithelial-Mesenchymal-Transition.
  8. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
  9. ROR-&#945;-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5.
  10. Down-regulation of ALDOB during metabolic reprogramming mediates malignant behavior in hepatocellular carcinoma and insensitivity to postoperative adjuvant transarterial chemoembolization.